Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2026-05-12 @ 11:43 PM
Study NCT ID:
NCT02539459
Status:
TERMINATED
Last Update Posted:
2022-12-15
First Post:
2015-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Sponsor:
Fox Chase Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GU-070
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |